Response to Letter to the Editor from Drs. Naoya Kataoka and Teruhiko Imamura.
作者信息
Azuma Mai, Kato Shingo
机构信息
Department of Cardiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Department of Diagnostic Radiology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
出版信息
Heart Vessels. 2025 Jun;40(6):558. doi: 10.1007/s00380-024-02503-5. Epub 2024 Dec 14.
PMID:39674818
Abstract
摘要
相似文献
1
Response to Letter to the Editor from Drs. Naoya Kataoka and Teruhiko Imamura.对片冈直也博士和今村辉彦博士致编辑信的回复。
Heart Vessels. 2025 Jun;40(6):558. doi: 10.1007/s00380-024-02503-5. Epub 2024 Dec 14.
2
Reply to Kataoka, N.; Imamura, T. How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on "Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412".对片冈直和、今村彻的回复。如何改善心动过速性心肌病患者的临床结局。对“卡茨等人。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412”的评论
J Clin Med. 2023 Sep 8;12(18):5849. doi: 10.3390/jcm12185849.
3
Response to the Letter to the Editor by Drs. Izumida and Imamura.对泉田博士和今村博士致编辑信的回复。
J Card Fail. 2020 Sep;26(9):809. doi: 10.1016/j.cardfail.2020.05.002. Epub 2020 May 16.
4
Patient reported QOL and EV-ICD: Response to letter from Kataoka and Imamura (2024).患者报告的生活质量与植入式心律转复除颤器：对片冈和今村来信（2024年）的回应
J Cardiovasc Electrophysiol. 2024 Feb;35(2):371-372. doi: 10.1111/jce.16175. Epub 2024 Jan 3.
5
Response to Letter by Kataoka and Imamura Regarding Article, "Short P-Wave Duration Is Associated with Incident Atrial Fibrillation".对片冈和今村就《短P波时限与新发房颤相关》一文所写信件的回复
Int Heart J. 2023 Mar 31;64(2):327-328. doi: 10.1536/ihj.22-454. Epub 2023 Mar 15.
6
Authors' Response to Teruhiko Imamura.作者对今村照彦的回应。
Transplant Proc. 2020 Dec;52(10):3236-3237. doi: 10.1016/j.transproceed.2020.04.1814. Epub 2020 Jun 20.
7
Letter by Kataoka and Imamura Regarding Article, "Impact of Preprocedural Frailty Status in Elderly Transvenous Pacemaker Recipients".片冈和今村就《老年经静脉起搏器植入患者术前衰弱状态的影响》一文所写的信。
Int Heart J. 2024;65(4):783. doi: 10.1536/ihj.24-050.
8
Reply to Letter by Kataoka and Imamura Regarding Article, "Impact of Preprocedural Frailty Status in Elderly Transvenous Pacemaker Recipients".对片冈和今村就《“老年经静脉起搏器植入患者术前衰弱状态的影响”一文》所写信件的回复
Int Heart J. 2024;65(4):784-785. doi: 10.1536/ihj.24-276.
9
Response to Dr. Masaya Miyauchi and Dr. Teruhiko Imamura, Clinical implication of COVID-19 associated bradycardia.对宫内正哉博士和今村辉彦博士的回应：新型冠状病毒肺炎相关心动过缓的临床意义
Clin Cardiol. 2021 Aug;44(8):1070-1071. doi: 10.1002/clc.23675. Epub 2021 Jul 9.
10
Author's reply: Prognostic implication of exercise echocardiography in patients with hypertrophic cardiomyopathy, by Teruhiko Imamura.
J Cardiol. 2021 Jun;77(6):677-678. doi: 10.1016/j.jjcc.2021.02.001. Epub 2021 Feb 13.
引用本文的文献
1
How to predict the presence of cardiac amyloidosis in patients with atrial fibrillation.如何预测心房颤动患者是否存在心脏淀粉样变性。
Heart Vessels. 2025 Jun;40(6):557. doi: 10.1007/s00380-024-02501-7. Epub 2024 Dec 2.
本文引用的文献
1
Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality.心脏淀粉样变中心律失常的导管消融：对心力衰竭和死亡率的影响。
PLoS One. 2024 Apr 5;19(4):e0301753. doi: 10.1371/journal.pone.0301753. eCollection 2024.
2
Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis.心脏淀粉样变患者行导管消融治疗心房颤动的安全性。
J Am Heart Assoc. 2023 Jul 18;12(14):e029339. doi: 10.1161/JAHA.122.029339. Epub 2023 Jul 14.
3
Atrial amyloidosis: mechanisms and clinical manifestations.心房淀粉样变：机制与临床表现。
Eur J Heart Fail. 2022 Nov;24(11):2019-2028. doi: 10.1002/ejhf.2650. Epub 2022 Aug 21.
4
Magnetic Resonance in Transthyretin Cardiac Amyloidosis.转甲状腺素蛋白心脏淀粉样变的磁共振成像。
J Am Coll Cardiol. 2017 Jul 25;70(4):466-477. doi: 10.1016/j.jacc.2017.05.053.
Zotero 插件